D68.32
BillableHemorrhagic disord d/t extrinsic circulating anticoagulants
Hemorrhagic disorder due to extrinsic circulating anticoagulants
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Drug-induced hemorrhagic disorder
- Hemorrhagic disorder due to increase in anti-IIa
- Hemorrhagic disorder due to increase in anti-Xa
- Hyperheparinemia
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Excludes 2
Conditions not included here, but the patient may have both
- •autoimmune disease (systemic) NOSM35.9
- •certain conditions originating in the perinatal periodP00-P96
- •complications of pregnancy, childbirth and the puerperiumO9A)O00
- •congenital malformations, deformations and chromosomal abnormalitiesQ00-Q99
- •endocrine, nutritional and metabolic diseasesE00-E88
- •human immunodeficiency virus [HIV] diseaseB20
- •injury, poisoning and certain other consequences of external causesS00-T88
- •neoplasmsC00-D49
- •symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedR00-R94
- •coagulation defects complicating abortion or ectopic or molar pregnancy,O00-O07, O08.1
- •coagulation defects complicating pregnancy, childbirth and the puerperium, , ,O45.0, O46.0, O67.0, O72.3
Use Additional Code
Additional codes that should follow this code
Also Known As / Clinical Terms(42)
SNOMED CT
- Drug-induced coagulation inhibitor disorder16773005
- Factor V inhibitor disorder41690001
- Acquired anticoagulants64509006
- Acquired coagulation factor inhibitor disorder64509006
- Circulating anticoagulant disorder64509006
- Hyperheparinaemia79674009
- Hyperheparinemia79674009
- Haemorrhagic disorder due to circulating anticoagulants191287000
- Hemorrhagic disorder due to circulating anticoagulants191287000
- Haemorrhagic disorder due to hyperheparinaemia191289002
- Hemorrhagic disorder due to hyperheparinemia191289002
- Haemorrhagic disorder due to increase in anti-10a191292003
- Hemorrhagic disorder due to increase in anti-10a191292003
- Anticoagulant-induced bleeding278365007
UMLS
- Drug-induced hemorrhagic disorderC2873795
- HYPERHEPARINEMIAC3203346
- HyperheparinaemiaC3203346
- HyperheparinemiaC3203346
- Hyperheparinemia (disorder)C3203346
- Hemorrhagic Disorder due to Extrinsic Circulating AnticoagulantsC2873796
- Hemorrhagic disord d/t extrinsic circulating anticoagulantsC2873796
- Hemorrhagic disorder due to extrinsic circulating anticoagulantsC2873796
- Hemorrhagic disorder due to increase in anti-IIaC3263947
- Hemorrhagic disorder due to increase in anti-XaC3263948
Clinical Terms
- Hyperheparinemia
- Haemorrhagic disorder due to circulating anticoagulants
- Hemorrhagic disorder due to increase in anti-IIa
- Haemorrhagic disorder due to increase in anti-10a
- Circulating anticoagulant disorder
- Hyperheparinaemia
- Factor V inhibitor disorder
- Drug-induced coagulation inhibitor disorder
- Hemorrhagic disorder due to increase in anti-10a
- Hemorrhagic disorder due to hyperheparinemia
- Acquired anticoagulants
- Haemorrhagic disorder due to hyperheparinaemia
- Hemorrhagic disorder due to circulating anticoagulants
- Anticoagulant-induced bleeding
- Drug-induced hemorrhagic disorder
- Hemorrhagic disorder due to increase in anti-Xa
- Hyperheparinemia (disorder)
- Acquired coagulation factor inhibitor disorder
Frequently Asked Questions
What is the ICD-10 code for hemorrhagic disord d/t extrinsic circulating anticoagulants?
The ICD-10-CM code for hemorrhagic disord d/t extrinsic circulating anticoagulants is D68.32. The full clinical description is "Hemorrhagic disorder due to extrinsic circulating anticoagulants". D68.32 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code D68.32 mean?
ICD-10-CM code D68.32 represents “Hemorrhagic disorder due to extrinsic circulating anticoagulants”. It is classified under Chapter 3: Diseases of the Blood and Blood-Forming Organs and is a billable/specific code that can be used on a claim.
Is D68.32 a billable code?
Yes, D68.32 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is D68.32 in?
D68.32 is in Chapter 3: Diseases of the Blood and Blood-Forming Organs (codes D50-D89).
What codes cannot be used with D68.32?
D68.32 has Excludes1 notes indicating codes that cannot be used together with it, including: abnormal coagulation profile NOS (R79.1).
Are additional codes required with D68.32?
Yes, when using D68.32, also report: adverse effect, if applicable, to identify drug (T45.515, T45.525).
What SNOMED CT codes does D68.32 map to?
D68.32 maps to 8 SNOMED CT concepts: 64509006, 278365007, 16773005, 41690001, 191287000, and 3 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for D68.32?
D68.32 is linked to 5 UMLS Concept Unique Identifiers: C2873795, C3203346, C2873796, C3263947, C3263948. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does D68.32 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like hemorrhagic disord d/t extrinsic circulating anticoagulants affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of D68.32?
There is no direct ICD-11 mapping available for D68.32 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.